
About Cerapedics
Cerapedics is a Healthcare company based in Westminster (United States) founded in 2006. Osteobiologic products are developed using synthetic peptide technology. Cerapedics has raised $88.46 million across 10 funding rounds from investors including GE Capital, Orbimed and Oxford Finance. The company has 3 employees. Its chief executive, as recorded, is Valeska Schroeder. Its website cerapedics.com draws about 18 thousand monthly visits. Cerapedics offers products and services including i-FACTOR P-15 Peptide Enhanced Bone Graft. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its legal entity is CERAPEDICS INC. Its competitors include MiMedx Group, EpiBone and Theradaptive; 2 of its 3 listed competitors have raised funding.
Company details
Cerapedics was founded in 2006 and is headquartered in Westminster, United States. Operations focus on the orthobiologics sector, where proprietary synthetic small peptide technology is developed and commercialized. The iFACTOR Peptide Enhanced Bone Graft is offered as a biologic bone graft that incorporates a small peptide to support natural bone healing. An FDA IDE trial for iFACTOR was completed, meeting all four prespecified primary endpoints.
- Headquarters Westminster, United States
- Employees 3
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cerapedics.com
- Social LinkedIn X Facebook
- Legal Name Cerapedics Inc
- Total Equity Funding$88.46M (USD)
in 10 rounds
- Latest Funding Round$22M (USD), Series D
Jul 2018
- InvestorsGE Capital
& 5 more
- Employee Count3
Products & Services of Cerapedics
Cerapedics offers a comprehensive portfolio of products and services, including i-FACTOR P-15 Peptide Enhanced Bone Graft.
FDA-approved product to accelerate bone healing in spine surgery.
Funding Insights of Cerapedics
Cerapedics has successfully raised a total of $88.46M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $22 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $88.46M
- Total Rounds 10
- Last Round Series D — $22M
- First Round $14.46M
(Sep 2007)
- Investors Count 6
All 10 funding rounds of Cerapedics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $22M | Series D | – | KCK MedTech | – |
| Apr 2017 | $20M | Debt – Conventional | – | – | |
| Sep 2016 | $11M | Series D | – | – | – |
| Apr 2015 | $4M | Debt – Conventional | – | – | |
| Feb 2015 | $4M | Series D | – | – | – |
| Apr 2014 | $9M | Debt – Venture | – | – | |
| Nov 2012 | $19M | Series C | – | MedImmune Ventures | |
| Feb 2012 | $3M | Series B | – | – | – |
| Mar 2009 | $15M | Series B | – | NGN Capital | |
| Sep 2007 | $14.46M | Series A | – | Orbimed | – |
6 investors in total: 6 institutional.
Investors in Cerapedics
Cerapedics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Capital, Orbimed and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| kckmedtech.com | ||||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
| medimmuneventures.com | ||||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
NGN Capital is engaged in venture capital investments. | ngncapital.com | New York, United States | ||
Commercial aircraft and equipment leasing and lending services are provided. | 1932 | gecapital.com | United States |
Investor details for Cerapedics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cerapedics
98 people are tracked at Cerapedics (30 in leadership, 7 in board & advisors, 61 in team); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Mani Gopal | Chief Operating Officer | Leadership |
Valeska Schroeder | CEO | Leadership |
Holly Smith | Vice President Operations | Leadership |
Katherine Lakstins, PhD | Director Medical Affairs/Medical Science Liaison | Leadership |
Rebecca Helpert | Director Commercial Operations & Excellence | Leadership |
Alanya M. | Director Of HR And Administration | Leadership |
Caryn Weaver | Senior People Business Partner | Leadership |
Lori Hays | Vice President Of Regulatory | Leadership |
Avi Aliyu | Senior Director Of Accounting | Leadership |
Kelley K. | Vice President, Global Commercial Operations & Development | Leadership |
Heath Thompson | Senior Director of Strategic Accounts, Americas | Leadership |
Tim Benoit-Ledoux | Vice President, Deputy General Counsel | Leadership |
Nathan Philipp | Chief Commercial Officer | Leadership |
Thomas Nardi | Associate Vice President Finance | Leadership |
Josef Vance | Vp, US Sales Operations | Leadership |
Sean L. | Area Vice President | Leadership |
Jeffrey G. Marx | Chief Scientific Officer | Leadership |
Brice Johnson | VP, Human Resources | Leadership |
Shankar Sivshankar | Director Clinical Operations | Leadership |
Genevra Enna | Vice President, Controller | Leadership |
78 more people are available in the full profile.
Complete people profiles for Cerapedics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cerapedics
3 dated milestones of Cerapedics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Cerapedics is founded.
- Funding First funding round of $14.5M.
- Funding Latest funding round, Series D, of $22.0M.
Competitors of Cerapedics
Cerapedics has 3 listed competitors in our database, 2 of them funded. They include MiMedx Group, EpiBone and Theradaptive.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | ||
| epibone.com | 2013 | Brooklyn, United States | $48.63M | Developer of stem cells to regrow damaged bones | ||
| theradaptive.com | 2004 | Boston, United States | $32.2M | 21 | Therapeutic delivery platform is developed for orthopedic clinical indications. |
Detailed competitors of Cerapedics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cerapedics
The website of Cerapedics (cerapedics.com) receives about 17.9K visits a month.
- Monthly visits17.9K
▼ 44.9% vs previous month
Top companies in Orthopedics
3 companies that operate in the same segment as Cerapedics (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cerapedics
Complete news archive for Cerapedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerapedics
Cerapedics was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Cerapedics is headquartered in Westminster, United States.
Valeska Schroeder is the CEO of Cerapedics, as recorded in our data.
Cerapedics is a funded company, having raised a total of $88.46M across 10 funding rounds to date. The company's 1st funding round was a Series A of $14.46M, raised on Sep 2007.
Cerapedics has 3 employees.
Cerapedics was founded in 2006 and is headquartered in Westminster, United States. Operations focus on the orthobiologics sector, where proprietary synthetic small peptide technology is developed and commercialized. The iFACTOR Peptide Enhanced Bone Graft is offered as a biologic bone graft that incorporates a small peptide to support natural bone healing. An FDA IDE trial for iFACTOR was completed, meeting all four prespecified primary endpoints.
Cerapedics's top competitors include EpiBone, Theradaptive and MiMedx Group.
Cerapedics offers i-FACTOR P-15 Peptide Enhanced Bone Graft.
Cerapedics has 6 investors. Key investors include GE Capital, Orbimed, Oxford Finance, KCK MedTech, and MedImmune Ventures.
Cerapedics operates through Cerapedics Inc.
